Active Ingredient History
Fostemsavir, sold under the brand name Rukobia, is an antiretroviral medication for adults living with HIV/AIDS who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
HIV Infections (approved 2020)
Bone Marrow Diseases (Phase 1)
Hematologic Diseases (Phase 1)
Hematologic Neoplasms (Phase 1)
HIV (Phase 2)
HIV Infections (Phase 4)
Leukemia (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Lymphoma (Phase 1)
Multiple Myeloma (Phase 1)
Myelodysplastic Syndromes (Phase 1)
Myeloproliferative Disorders (Phase 1)
Neoplasms (Phase 1)
Neoplasms by Histologic Type (Phase 1)
Peripheral Nervous System Neoplasms (Phase 2)
Polycythemia Vera (Phase 3)
Precancerous Conditions (Phase 1)
Preleukemia (Phase 1)
Primary Myelofibrosis (Phase 3)
Thrombocytosis (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
